Treatment of postmenopausal breast cancer with bisbromoacetyl hexestrol.
Twenty five cases of advanced postmenopausal breast cancer patients were treated with bisbromoacetyl hexestrol 3 CR and 5 PR were achieved. The response rate was 32%, and the average duration of remission 6 months. Vaginal bleeding was seen in 9 cases, 4 of whom were compelled to discontinue treatment.
Zhao
T
T
Medical Oncology Department, Shanghai Cancer Hospital, Shanghai, China.
He
G
G
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006589:Hexestrol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008593:Menopause; D008875:Middle Aged
D000970:Antineoplastic Agents; D006589:Hexestrol; C042119:bis(bromoacetyl)hexestrol